Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Sep. 30, 2020
Cash flows from operating activities
Net loss	$ (8,004,000)	$ (10,796,000)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	240,000	125,000
Impairment of long-lived assets	0	2,870,000	$ 5,800,000
Stock-based compensation expense	505,000	717,000
Write-off lease receivable/prepaid commission assets		1,383,000
Changes in assets and liabilities
Prepaid expenses and other assets	(1,656,000)	1,188,000
Accounts payable	443,000	110,000
Deferred revenue	(256,000)
Accrued and other liabilities	(1,291,000)	(59,000)
Net cash used in operating activities	(10,019,000)	(4,462,000)
Cash flows from financing activities
Proceeds from issuance of common stock in connection with employee benefit plans		33,000
Proceeds from issuance of common stock in connection with exercise of options	260,000
Proceeds from issuance of common stock in direct offering, net of issuance costs	20,866,000
Proceeds from issuance of common stock in at-the-market offering	7,034,000
Net cash provided by financing activities	28,160,000	33,000
Net change in cash, cash equivalents, and restricted cash	18,141,000	(4,429,000)
Cash, cash equivalents, and restricted cash at beginning of period	62,971,000	67,557,000	$ 67,557,000
Cash, cash equivalents, and restricted cash at end of period	$ 81,112,000	$ 63,128,000